Dual TLR2 and TLR7 agonists as HIV latency-reversing agents.
Macedo AB, Novis CL, De Assis CM, Sorensen ES, Moszczynski P, Huang SH, Ren Y, Spivak AM, Jones RB, Planelles V, Bosque A.
Macedo AB, et al. Among authors: de assis cm.
JCI Insight. 2018 Oct 4;3(19):e122673. doi: 10.1172/jci.insight.122673.
JCI Insight. 2018.
PMID: 30282829
Free PMC article.